Domains pointed to ns2.mnk.com
These websites are known to have been using ns2.mnk.com as their DNS nameserver.
Number of websites/domains displayed: 10
Results found: 10
Websites discovered:
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceuticalhttp://pageoverview.com/website-report/mnk.com
As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.
- Expected expiration: July 3rd in 2017
- Creation date: July 4th in 1996
- Renew date: June 29th in 2016
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceuticalhttp://pageoverview.com/website-report/infantilespasmscenter.org
As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.
- Expected expiration: August 29th in 2018
- Creation date: August 29th in 2008
- Renew date: August 25th in 2017
ikaria.comhttp://pageoverview.com/website-report/ikaria.com
- Expected expiration: March 25th in 2021
- Creation date: March 24th in 1997
- Renew date: July 16th in 2015
Mallinckrodt Pharmaceuticals | Global Specialty Biopharmaceuticalhttp://pageoverview.com/website-report/mallinckrodt.com
As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.
- Expected expiration: September 9th in 2017
- Creation date: September 10th in 1996
- Renew date: September 5th in 2016
Therakos, Inc. - The Global Leader in Autologous Immune Cell Therapyhttp://pageoverview.com/website-report/therakos.com
Therakos is focused on providing innovative treatment platforms that harness the power of each individual patient’s immune system to fiight diseases
- Expected expiration: November 6th in 2017
- Creation date: November 7th in 1995
- Renew date: November 2nd in 2016
- Google Analytics: 57221743-1
Loginhttp://pageoverview.com/website-report/mymallinckrodtmeetings.com
- Expected expiration: February 27th in 2018
- Creation date: February 27th in 2015
- Renew date: February 23rd in 2017
INOMAX, a Nitric Oxide Vasodilator | INOMAXhttp://pageoverview.com/website-report/inomax.com
INOMAX® treats hypoxic respiratory failure (HRF) in term and near-term infants.
- Expected expiration: November 29th in 2018
- Creation date: November 30th in 1998
- Renew date: November 25th in 2017
- Google Analytics: 12710347-1